Sandoz Montelukast Chewable Tablets 5 mg (Montelukast Sodium)
Montelukast Sodium
Prescription medication
Sandoz Korea Co., Ltd.
MFDS item code 201206474 · Approved 2012.08.16
This product's status changed to Company closed on 2023.07.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Prevention and long-term treatment of asthma; relief of allergic rhinitis symptoms
This medication helps prevent the occurrence of asthma and continuously manage its symptoms. It also alleviates the uncomfortable symptoms of allergic rhinitis that may occur seasonally or year-round. This maintains respiratory health and reduces discomfort in daily life. It is used to effectively improve symptoms of asthma and allergic rhinitis.
Take this medicine once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 packet, or 1 film once daily in the evening. 10 mg tablet Adults and adolescents aged 15 years and older: Administer 10 mg of montelukast orally once daily. 10 mg orally disintegrating film Adults and adolescents aged 15 years and older: Place 10 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water.
5 mg chewable tablet Children aged 6~14 years: Chew and take 5 mg of montelukast once daily. Administer this medicine 1 hour before or 2 hours after a meal. 4 mg chewable tablet Children aged 2~5 years: Chew and take 4 mg of montelukast once daily. Administer this medicine 1 hour before or 2 hours after a meal. 5 mg orally disintegrating tablet Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily and, after it disintegrates, take without water. Administer this medicine 1 hour before or 2 hours after a meal. 4 mg orally disintegrating tablet Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily and, after it disintegrates, take without water. Administer this medicine 1 hour before or 2 hours after a meal. 5 mg orally disintegrating film Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Administer this medicine 1 hour before or 2 hours after a meal. 4 mg orally disintegrating film Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Administer this medicine 1 hour before or 2 hours after a meal. 5 mg dry syrup Children aged 6~14 years: Administer 5mg of montelukast orally once daily. Administer this medicine 1 hour before or 2 hours after a meal. 4 mg granules Asthma Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Infants aged 12 months~under 2 years: Administer 4 mg of this medicine orally once daily in the evening. Efficacy and safety for asthma have not been established in infants younger than 12 months. Allergic rhinitis Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants younger than 2 years. Infants aged 6 months~under 2 years: Administer 4mg of this medicine orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants younger than 6 months. ○ Directions for taking dry syrup (for syrup only) To take, pour 1 packet of this medicine into a cup, add 10 mL of water, stir well, and take. Do not open the package until immediately before use. After opening, immediately (within 15 minutes) suspend the contents in water and take the entire amount. Do not leave this medicine suspended in water for an extended period. ○ Directions for taking granules (for granules only) The 4 mg granules of this medicine may be taken directly by mouth or mixed with a small amount (approximately 5 mL) of soft food, such as infant food, breast milk, or porridge, at room temperature or cooler. Do not open the package until immediately before use. After opening, immediately (within 15 minutes) mix with infant food, breast milk, or food, or take the entire amount as is. Do not leave this medicine mixed with infant food, breast milk, or food for an extended period; discard any remaining amount. This formulation is not designed to be mixed with beverages other than infant food or breast milk, but a beverage may be taken immediately after administration. This medicine may be taken without regard to meals.
This medication contains the artificial sweetener aspartame, and should not be taken by patients with phenylketonuria, a hereditary disorder. Aspartame is broken down into phenylalanine in the body, so patients with this condition must restrict their intake of phenylalanine. Also, care should be taken to not exceed the daily allowable intake of aspartame, which for adults should be no more than 2.4 grams per day. This medication should not be used by persons with hypersensitivity to any of its ingredients or by patients with lactose intolerance or certain hereditary metabolic disorders. During use, side effects such as fatigue, headache, indigestion, cough, and rash may occur, so it is important to monitor one’s health closely. Asthma patients should note that this medication is not an immediate treatment during an acute attack, and should always carry an emergency inhaler. Ensure not to abruptly discontinue or replace inhaled corticosteroids without a doctor's instruction. While using this medication, avoid taking aspirin or non-steroidal anti-inflammatory drugs, especially if there is an allergy to aspirin. Rarely, systemic eosinophilia or vasculitis symptoms may occur in asthma patients, and if such symptoms are suspected, contact a physician immediately. Pregnant women should always consult a doctor before taking this medication, and nursing mothers should also be cautious. Careful consideration must be given to dosage and administration for children and the elderly based on their age. In case of overdose, there are no specific antidotes, and immediate medical attention should be sought. This medication is sensitive to light, so do not open until right before use, and store out of reach of children. If any neuropsychiatric symptoms or adverse reactions occur during use, inform your doctor immediately and do not discontinue or change other asthma treatments without a doctor's prescription.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture, and keep it away from direct sunlight at room temperature between 1°C and 30°C. This storage method helps maintain the medication's efficacy for a longer period.
Round, pink, biconvex chewable tablet
Manufacturer packaging unit
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Montelukast Sodium
Prescription medication
Sandoz Korea Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.